Format

Send to

Choose Destination
Genome Announc. 2016 May 19;4(3). pii: e00373-16. doi: 10.1128/genomeA.00373-16.

Genome Sequence of Serratia plymuthica A153, a Model Rhizobacterium for the Investigation of the Synthesis and Regulation of Haterumalides, Zeamine, and Andrimid.

Author information

1
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom Department of Environmental Protection, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Granada, Spain gpcs2@cam.ac.uk miguel.matilla@eez.csic.es.
2
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
3
Abengoa Research, Biotechnology Technological Area, Sevilla, Spain.
4
Department of Environmental Protection, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Granada, Spain.
5
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom gpcs2@cam.ac.uk miguel.matilla@eez.csic.es.

Abstract

The rhizobacterium Serratia plymuthica A153 is a Gram-negative bacterium belonging to the family Enterobacteriaceae Here, we present the genome sequence of this strain, which produces multiple bioactive secondary metabolites, including the halogenated macrolide oocydin A, the polyamino antibiotic zeamine, and the bacterial acetyl-CoA carboxylase inhibitor andrimid.

Supplemental Content

Full text links

Icon for American Society for Microbiology Icon for PubMed Central
Loading ...
Support Center